Helping you find answers for families affected by hereditary cancer

Oncology

Code Test Genes TAT
8824 CancerNext®
 		APC, ATM, AXIN2, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, EPCAM, FH, FLCN, GREM1, HOXB13, MBD4, MET, MLH1, MSH2, MSH3, MSH6, MUTYH, NF1, NTHL1, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, SMAD4, STK11, TP53, TSC1, TSC2, VHL 14-21 days
8875 CancerNext-Expanded®
 		AIP, ALK, APC, ATM, AXIN2, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CEBPA, CHEK2, CTNNA1, DDX41, DICER1, EGFR, EPCAM, ETV6, FH, FLCN, GATA2, GREM1, HOXB13, KIT, LZTR1, MAX, MBD4, MEN1, MET, MITF, MLH1, MSH2, MSH3, MSH6, MUTYH, NF1, NF2, NTHL1, PALB2, PDGFRA, PHOX2B, PMS2, POLD1, POLE, POT1, PRKAR1A, PTCH1, PTEN, RAD51C, RAD51D, RB1, RET, RUNX1, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, SMARCA4, SMARCB1, SMARCE1, STK11, SUFU, TMEM127, TP53, TSC1, TSC2, VHL, WT1 14-21 days
8836 BRCAplus®
 		ATM, BARD1, BRCA1, BRCA2, CDH1, CHEK2, NF1, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53 7-10 days
8857 BRCANext®
 		ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM, MLH1, MSH2, MSH6, NF1, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53 14-21 days
8821 ColoNext®
 		APC, AXIN2, BMPR1A, CDH1, EPCAM, GREM1, MBD4, MLH1, MSH2, MSH3, MSH6, MUTYH, NTHL1, PMS2, POLD1, POLE, PTEN, SMAD4, STK11, TP53 14-21 days
9511 CustomNext-Cancer®
 		AIP, ALK, APC, ATM, ATRIP, AXIN2, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CEBPA, CFTR, CHEK2, CPA1, CTNNA1, CTRC, DDX41, DICER1, EGFR, EGLN1, EPCAM, ETV6, FH, FLCN, GATA2, GREM1, HOXB13, KIF1B, KIT, LZTR1, MAX, MBD4, MEN1, MET, MITF, MLH1, MLH3, MSH2, MSH3, MSH6, MUTYH, NF1, NF2, NTHL1, PALB2, PALLD, PDGFRA, PHOX2B, PMS2, POLD1, POLE, POT1, PRKAR1A, PRSS1, PTCH1, PTEN, RAD51B, RAD51C, RAD51D, RB1, RET, RNF43, RPS20, RUNX1, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, SMARCA4, SMARCB1, SMARCE1, SPINK1, STK11, SUFU, TERT, TMEM127, TP53, TSC1, TSC2, VHL, WT1 14-21 days
3040 APC seq and del/dup
Adenomatous polyposis
 Familial adenomatous polyposis (FAP)
 		APC 14-21 days
9014 ATM seq and del/dup
 		ATM 14-21 days
9044 BAP1 seq and del/dup BAP1 14-21 days
8838 BRCA1/2 seq and del/dup
 		BRCA1, BRCA2 6-10 days
8604 BMPR1A & SMAD4 seq and del/dup
 		BMPR1A, SMAD4 14-21 days
4726 CDH1 seq and del/dup
 		CDH1 14-21 days
4708 CDKN2A & CDK4 seq and del/dup CDK4, CDKN2A 14-21 days
9016 CHEK2 seq and del/dup
 		CHEK2 14-21 days
5260 DICER1 seq and del/dup
 		DICER1 14-21 days
8519 HNPCC/Lynch del/dup EPCAM, MLH1, MSH2 7-14 days
6301 FH seq and del/dup
 		FH 14-21 days
5921 FLCN seq and del/dup
 		FLCN 14-21 days
2646 MEN1 seq and del/dup
 		MEN1 14-21 days
9046 MITF specific site analysis MITF 7-14 days
8508 MLH1 seq and del/dup
 		MLH1 14-21 days
8510 MSH2 seq & del/dup & EPCAM del/dup
 		EPCAM, MSH2 14-21 days
8512 MSH6 seq and del/dup
 		MSH6 14-21 days
4661 MUTYH seq and del/dup
Adenomatous polyposis
 MUTYH-associated polyposis (MAP)
 		MUTYH 14-21 days
5704 NF1 seq and del/dup
 		NF1 14-21 days
9024 NF2 seq and del/dup
 		NF2 14-21 days
2366 PALB2 seq and del/dup
 		PALB2 14-21 days
4646 PMS2 seq and del/dup
 		PMS2 14-21 days
5684 PTCH1 seq and del/dup
 		PTCH1 14-21 days
2106 PTEN seq and del/dup
 		PTEN 14-21 days
5426 RB1 seq and del/dup
 		RB1 14-21 days
2680 RET seq
Multiple endocrine neoplasia type 2 (MEN2) and familial medullary thyroid cancer (FMTC)
 RET-related Hirschsprung disease
 		RET 14-21 days
7180 SMARCB1 seq and del/dup
 		SMARCB1 14-21 days
2766 STK11 seq and del/dup
 		STK11 14-21 days
2866 TP53 seq and del/dup
 		TP53 14-21 days
5904 TSC1/2 seq and del/dup
 		TSC1, TSC2 14-21 days
2606 VHL seq and del/dup
 		VHL 14-21 days

Please select a category to find your test or learn more about our highlighted tests below

  • Highlighted Tests

    • why choose ambry

      Ambry places significant value on implementing new lab processes designed to increase quality, and advancing technology across the field with innovative approaches. Our ongoing participation in numerous research studies and collaborations is so that we can better assess clinical validity of gene-disease relationships. This is to ensure that the results healthcare providers receive are as accurate and informative as possible. That’s why we led the largest study of its kind (20,000 cases) guiding us on additional confirmatory testing when we saw specific well-defined thresholds, reducing the chance of delivering a false positive patient report or one that misses real mutations (Mu et al., November 2016). The more accurate the reports, the more insight healthcare providers will have to treat their patients.

      Choose from one of our more frequently ordered tests listed below.

      CancerNext®

      CancerNext is a guideline-based, pan-cancer test that includes 39 genes associated with the most common hereditary cancer types, including hereditary breast, ovarian, pancreatic, prostate, colorectal/polyps, endometrial, gastric, small bowel, urothelial, and renal cancers.

      CancerNext-Expanded®

      As Ambry’s most comprehensive, pan-cancer test option for hereditary cancer predisposition, CancerNext-Expanded includes up to 90 genes associated with a wide range of hereditary cancers such as breast, ovarian, uterine, colorectal, gastric, pancreatic, prostate, melanoma, renal, central nervous system tumors, pheochromocytoma/paraganglioma, hematologic malignancy, and other rare cancer predisposition conditions.

      BRCAplus®

      BRCAplus is a guideline-based, disease-specific test option that includes 13 genes associated with hereditary breast cancer, where screening and/or surgical intervention may be indicated.

      BRCANext®

      BRCANext is a guideline-based, disease-specific test option that includes up to 26 genes associated with hereditary breast and/or gynecologic cancers.

      ColoNext®

      ColoNext is a guideline-based, disease-specific test option that includes up to 26 genes associated with hereditary colorectal and gastric cancer and polyposis.

  • Comprehensive
    • Comprehensive Testing

      • Comprehensive

        Comprehensive Testing

        Name TAT Genes
        CancerNext® 14-21 days 39
        CancerNext-Expanded® 14-21 days 76
    • Customizable Testing

      • Comprehensive

        Customizable Testing

        Name TAT Genes
        CustomNext-Cancer® 14-21 days 90
  • Breast + Gynecological
  • Gastrointestinal
  • Single Gene

    • Single Gene

      Single gene or single syndrome testing options

      Name TAT
      APC gene sequence and deletion/duplication analysis 14-21 days
      ATM gene sequence and deletion/duplication analysis 14-21 days
      BAP1 gene sequence and deletion/duplication analysis 14-21 days
      BRCA1/BRCA2 gene sequence and deletion/duplication analysis 6-10 days
      BMPR1A/SMAD4 gene sequence and deletion/duplication analysis 14-21 days
      CDH1 gene sequence and deletion/duplication analysis 14-21 days
      CDKN2A/CDK4 gene sequence and deletion/duplication analysis 14-21 days
      CHEK2 gene sequence and deletion/duplication analysis 14-21 days
      DICER1 gene sequence and deletion/duplication analysis 14-21 days
      EPCAM deletion/duplication analysis 7-14 days
      FH gene sequence and deletion/duplication analysis 14-21 days
      FLCN gene sequence and deletion/duplication analysis 14-21 days
      MEN1 gene sequence and deletion/duplication analysis 14-21 days
      MITF specific site analysis 7-14 days
      MLH1 gene sequence and deletion/duplication analysis 14-21 days
      MSH2 gene sequence and deletion/duplication analysis, MSH2 inversion analysis, and EPCAM deletion/duplication analysis 14-21 days
      MSH6 gene sequence and deletion/duplication analysis 14-21 days
      MUTYH gene sequence and deletion/duplication analysis 14-21 days
      NF1 gene sequence and deletion/duplication analysis 14-21 days
      NF2 gene sequence and deletion/duplication 14-21 days
      PALB2 gene sequence and deletion/duplication analysis 14-21 days
      PMS2 gene sequence and deletion/duplication analysis 14-21 days
      PTCH1 gene sequence and deletion/duplication analysis 14-21 days
      PTEN gene sequence and deletion/duplication analysis 14-21 days
      RB1 gene sequence and deletion/duplication analysis 14-21 days
      RET gene sequence 14-21 days
      SMARCB1 gene sequence and deletion/duplication 14-21 days
      STK11 gene sequence and deletion/duplication analysis 14-21 days
      TP53 gene sequence and deletion/duplication analysis 14-21 days
      TSC1/TSC2 gene sequence and deletion/duplication analysis 14-21 days
      VHL gene sequence and deletion/duplication analysis 14-21 days

Patients

Providers

Partners

CARE

Science

Company

Search Results

Start your search...